Anticoagulant Drugs clinical trials at UCSF
1 in progress, 0 open to new patients
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombolytic Events) in Children at Risk Because of Cardiac Disease
Sorry, not yet accepting patients
A committee will judge the safety and effectiveness of edoxaban and the regular treatment (standard of care). All children in the study will receive free treatment. They will have a 2 in 3 chance to receive edoxaban, and a 1 in 3 chance to receive the standard of care for preventing blood clots. The study will find out if edoxaban is safer and more effective than the standard of care.
San Francisco, California and other locations